Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2 results about "Cartilage disorder" patented technology

Condition in which there is a deviation from or interruption of the normal structure or function of cartilage, the non-vascular form of connective tissue composed of chondrocytes embedded in a matrix of type II collagen and chondroitin sulfate.

Methods of using the brain-derived osteogenic factor ccn3 for treating bone and cartilage degeneration

Methods of using cell communication network factor 3 (CCN3) for the treatment of bone or cartilage disorders are provided. Also provided are methods of gene therapy, including methods of expressing CCN3 in vivo in an amount effective to promote new bone or cartilage growth. In addition, methods of screening for agonists, mimetics, and analogs of CCN3 are provided.
Owner:RGT UNIV OF CALIFORNIA +1

Compositions for use in stimulating bone growth

To provide a composition for maintaining bone and / or cartilage health, or for preventing, alleviating and / or treating bone and / or cartilage disorders.SOLUTION: There is provided a composition comprising Vitamin D and oleuropein for use to enhance the stimulation of bone formation by oleuropein, wherein the composition comprises between 800 and 1200IU of Vitamin D and between 0. 01mg and 1g of oleuropein. The composition may further comprise one or more bioactive molecules selected from the group consisting of antioxidants, anti-inflammatory compounds, fatty acids, prebiotic fibers, probiotics, glucosamine, chondroitin sulfate, minerals, trace elements and vitamins.SELECTED DRAWING: None
Owner:SOCIETE DES PRODUITS NESTLE SA